Citicoline vs Alpha-GPC
Both supply choline for acetylcholine and membrane phospholipids. Citicoline also provides cytidine (converted to uridine) and has been tested in large stroke trials; alpha-GPC was studied in dementia and cognition.
Citicoline
A naturally occurring intermediate in phosphatidylcholine synthesis, studied as a neuroprotective and cognitive compound.
BEST STUDIED FOR
Nootropic & neuro
Read the cited profile →
Alpha-GPC
A choline-containing phospholipid and acetylcholine precursor used as a medicine or nutraceutical for cognition.
BEST STUDIED FOR
Nootropic & neuro
Read the cited profile →
SIDE BY SIDE
| Citicoline | Alpha-GPC | |
|---|---|---|
| The key difference | CDP-choline (choline + cytidine) | Glycerophosphocholine |
| Class | Nootropic & neuro | Nootropic & neuro |
| Mechanism | Citicoline supplies choline and cytidine for neuronal membrane phospholipids and influences acetylcholine, dopamine and glutamate systems. | Alpha-GPC delivers choline to the brain for acetylcholine synthesis and membrane phospholipids; animal work reports increased hippocampal neurogenesis. |
| Status | Registered medicine in several countries (stroke, cognitive impairment) and a supplement elsewhere; evidence in stroke is debated. | Prescription medicine in some countries (cognitive decline) and a supplement elsewhere; a 2023 meta-analysis covers adult-onset cognitive dysfunction. |
| Reported safety signals | Reviews describe a favourable safety profile. | Generally well tolerated in trials. |
| A key study | A comprehensive pharmacological and clinical review of citicoline. (Rev Neurol 2022, PMID 36544369) | A meta-analysis of choline alfoscerate in adult-onset cognitive dysfunction. (J Alzheimers Dis 2023, PMID 36683513) |
WHEN TO RESEARCH WHICH
Citicoline for membrane-repair and stroke research; alpha-GPC for cholinergic research. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.
REFERENCES (PUBMED)
- [Citicoline] Citicoline: pharmacological and clinical review, 2022 update — Rev Neurol 2022. PMID 36544369
- [Citicoline] Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial — J Nutr 2021. PMID 33978188
- [Citicoline] Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis — Nutrients 2023. PMID 36678257
- [Alpha-GPC] Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis — J Alzheimers Dis 2023. PMID 36683513
- [Alpha-GPC] Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men — Nutrients 2024. PMID 39683633
- [Alpha-GPC] Choline supplements: An update — Front Endocrinol (Lausanne) 2023. PMID 36950691
FREQUENTLY ASKED
What is the difference between Citicoline and Alpha-GPC?
Both supply choline for acetylcholine and membrane phospholipids. Citicoline also provides cytidine (converted to uridine) and has been tested in large stroke trials; alpha-GPC was studied in dementia and cognition.
What is the regulatory status of Citicoline and Alpha-GPC?
Citicoline: Registered medicine in several countries (stroke, cognitive impairment) and a supplement elsewhere; evidence in stroke is debated. Alpha-GPC: Prescription medicine in some countries (cognitive decline) and a supplement elsewhere; a 2023 meta-analysis covers adult-onset cognitive dysfunction.
What safety signals have been reported?
Citicoline: Reviews describe a favourable safety profile. Alpha-GPC: Generally well tolerated in trials.
Which studies is this comparison based on?
For Citicoline: “Citicoline: pharmacological and clinical review, 2022 update” (PMID 36544369); “Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” (PMID 33978188); “Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis” (PMID 36678257). For Alpha-GPC: “Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis” (PMID 36683513); “Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men” (PMID 39683633); “Choline supplements: An update” (PMID 36950691).
MORE COMPARISONS
All products supplied for research purposes only. Not for human consumption.
In stock · ships from South Africa
In stock now
Supplied for laboratory research only · not for human use